US Stock MarketDetailed Quotes

MDxHealth (MDXH)

Watchlist
  • 4.020
  • -0.130-3.13%
Trading Jan 23 13:12 ET
206.49MMarket Cap-7.73P/E (TTM)

MDxHealth (MDXH) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
17.65%27.43M
20.06%26.61M
22.48%24.29M
28.29%90.05M
27.53%24.74M
20.50%23.32M
32.33%22.16M
34.93%19.83M
89.43%70.19M
50.48%19.4M
Operating revenue
17.65%27.43M
20.16%26.59M
22.48%24.29M
29.81%72.33M
42.58%7.02M
20.50%23.32M
32.95%22.13M
34.93%19.83M
78.86%55.72M
-30.07%4.92M
Cost of revenue
5.71%9.56M
1.86%9.04M
13.09%8.79M
32.91%34.91M
37.09%9.22M
33.03%9.04M
31.35%8.87M
29.84%7.77M
47.26%26.26M
18.70%6.73M
Gross profit
25.22%17.88M
32.22%17.57M
28.53%15.5M
25.52%55.14M
22.46%15.52M
13.72%14.28M
32.99%13.29M
38.42%12.06M
128.57%43.93M
75.40%12.67M
Operating expense
0.74%20.52M
-5.90%19.48M
7.63%20.09M
12.03%79.17M
5.66%19.43M
19.01%20.37M
16.75%20.7M
7.08%18.67M
22.62%70.67M
10.21%18.39M
Selling and administrative expenses
10.35%18.05M
-1.93%16.16M
1.79%15.66M
5.31%61.4M
-9.66%13.18M
13.25%16.35M
9.82%16.48M
7.84%15.39M
22.66%58.3M
19.85%14.59M
-Selling and marketing expense
-0.29%10.59M
-6.69%9.92M
-2.06%9.82M
-12.53%6.44M
-23.78%-24.84M
17.21%10.62M
14.68%10.63M
10.21%10.03M
59.24%7.37M
-54.43%-20.07M
-General and administrative expense
30.06%7.46M
6.73%6.24M
9.01%5.84M
7.89%54.95M
9.70%38.02M
6.58%5.74M
1.95%5.84M
3.68%5.36M
18.72%50.94M
37.70%34.66M
Research and development costs
-25.58%2.01M
-11.57%2.57M
15.48%2.5M
65.50%10.55M
52.43%2.79M
73.22%2.7M
73.42%2.9M
64.44%2.16M
15.99%6.38M
817.25%1.83M
Depreciation amortization depletion
-2.26%1.3M
17.54%1.32M
17.51%1.32M
19.15%7.29M
35.03%3.72M
17.64%1.33M
0.72%1.12M
0.09%1.13M
31.51%6.12M
--2.75M
-Depreciation and amortization
-2.26%1.3M
17.54%1.32M
17.51%1.32M
19.15%7.29M
35.03%3.72M
17.64%1.33M
0.72%1.12M
0.09%1.13M
31.51%6.12M
--2.75M
Other operating expenses
-7,481.82%-834K
-376.35%-561K
6,855.56%608K
44.09%-71K
67.48%-254K
8.33%-11K
450.00%203K
-101.24%-9K
-188.64%-127K
-779.13%-781K
Operating profit
56.63%-2.64M
74.17%-1.92M
30.53%-4.59M
10.14%-24.03M
31.57%-3.91M
-33.57%-6.09M
4.20%-7.42M
24.24%-6.6M
30.39%-26.74M
39.57%-5.72M
Net non-operating interest income expense
-12.83%-5.37M
-42.87%-5.87M
-135.13%-4.48M
-18.17%-6.87M
-29.48%3.91M
13.15%-4.76M
-1,021.52%-4.11M
36.26%-1.91M
-122.00%-5.81M
3,303.07%5.55M
Non-operating interest income
154.82%502K
54.98%420K
-49.53%692K
-0.92%1.08M
-43.98%-694K
-65.07%197K
--271K
--1.37M
770.40%1.09M
---482K
Non-operating interest expense
18.47%5.88M
43.62%6.29M
57.90%5.18M
36.67%7.63M
32.99%-4.92M
-17.99%4.96M
2,346.67%4.38M
9.56%3.28M
111.76%5.58M
-4,966.90%-7.35M
Total other finance cost
----
----
----
-75.95%317K
----
----
----
----
1,131.78%1.32M
----
Other net income (expense)
35.61%-6.79M
-250.32%-10.55M
Gain on sale of security
----
----
----
216.75%941K
----
----
----
----
-794.83%-806K
----
Special income (charges)
----
----
----
20.62%-7.73M
----
----
----
----
-211.54%-9.74M
----
-Less:Restructuring and merger&acquisition
----
----
----
-52.75%4.6M
----
----
----
----
368.37%9.74M
----
-Less:Other special charges
----
----
----
--3.13M
----
----
----
----
----
----
Income before tax
26.15%-8.02M
32.44%-7.79M
-6.59%-9.07M
12.56%-37.69M
36.63%-6.79M
-8.06%-10.86M
-8.49%-11.53M
27.31%-8.51M
2.15%-43.1M
12.92%-10.72M
Income tax
-101.80%-6K
-416K
137K
38,100.00%382K
4,700.00%48K
334K
0
0
1K
-99.22%1K
Net income
28.41%-8.01M
36.05%-7.37M
-8.20%-9.21M
11.67%-38.07M
36.18%-6.84M
-11.39%-11.19M
-8.49%-11.53M
27.31%-8.51M
2.14%-43.1M
13.81%-10.72M
Net income continuous Operations
28.41%-8.01M
36.05%-7.37M
-8.20%-9.21M
11.67%-38.07M
36.18%-6.84M
-11.39%-11.19M
-8.49%-11.53M
27.31%-8.51M
2.14%-43.1M
13.81%-10.72M
Minority interest income
Net income attributable to the parent company
28.41%-8.01M
36.05%-7.37M
-8.20%-9.21M
11.67%-38.07M
36.18%-6.84M
-11.39%-11.19M
-8.49%-11.53M
27.31%-8.51M
2.14%-43.1M
13.81%-10.72M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
28.41%-8.01M
36.05%-7.37M
-8.20%-9.21M
11.67%-38.07M
36.18%-6.84M
-11.39%-11.19M
-8.49%-11.53M
27.31%-8.51M
2.14%-43.1M
13.81%-10.72M
Basic earnings per share
60.00%-0.16
66.67%-0.14
38.71%-0.19
30.12%-1.16
64.10%-0.14
-8.11%-0.4
-10.53%-0.42
41.51%-0.31
40.29%-1.66
50.00%-0.39
Diluted earnings per share
60.00%-0.16
66.67%-0.14
38.71%-0.19
30.12%-1.16
64.10%-0.14
-8.11%-0.4
-10.53%-0.42
41.51%-0.31
40.29%-1.66
50.00%-0.39
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 17.65%27.43M20.06%26.61M22.48%24.29M28.29%90.05M27.53%24.74M20.50%23.32M32.33%22.16M34.93%19.83M89.43%70.19M50.48%19.4M
Operating revenue 17.65%27.43M20.16%26.59M22.48%24.29M29.81%72.33M42.58%7.02M20.50%23.32M32.95%22.13M34.93%19.83M78.86%55.72M-30.07%4.92M
Cost of revenue 5.71%9.56M1.86%9.04M13.09%8.79M32.91%34.91M37.09%9.22M33.03%9.04M31.35%8.87M29.84%7.77M47.26%26.26M18.70%6.73M
Gross profit 25.22%17.88M32.22%17.57M28.53%15.5M25.52%55.14M22.46%15.52M13.72%14.28M32.99%13.29M38.42%12.06M128.57%43.93M75.40%12.67M
Operating expense 0.74%20.52M-5.90%19.48M7.63%20.09M12.03%79.17M5.66%19.43M19.01%20.37M16.75%20.7M7.08%18.67M22.62%70.67M10.21%18.39M
Selling and administrative expenses 10.35%18.05M-1.93%16.16M1.79%15.66M5.31%61.4M-9.66%13.18M13.25%16.35M9.82%16.48M7.84%15.39M22.66%58.3M19.85%14.59M
-Selling and marketing expense -0.29%10.59M-6.69%9.92M-2.06%9.82M-12.53%6.44M-23.78%-24.84M17.21%10.62M14.68%10.63M10.21%10.03M59.24%7.37M-54.43%-20.07M
-General and administrative expense 30.06%7.46M6.73%6.24M9.01%5.84M7.89%54.95M9.70%38.02M6.58%5.74M1.95%5.84M3.68%5.36M18.72%50.94M37.70%34.66M
Research and development costs -25.58%2.01M-11.57%2.57M15.48%2.5M65.50%10.55M52.43%2.79M73.22%2.7M73.42%2.9M64.44%2.16M15.99%6.38M817.25%1.83M
Depreciation amortization depletion -2.26%1.3M17.54%1.32M17.51%1.32M19.15%7.29M35.03%3.72M17.64%1.33M0.72%1.12M0.09%1.13M31.51%6.12M--2.75M
-Depreciation and amortization -2.26%1.3M17.54%1.32M17.51%1.32M19.15%7.29M35.03%3.72M17.64%1.33M0.72%1.12M0.09%1.13M31.51%6.12M--2.75M
Other operating expenses -7,481.82%-834K-376.35%-561K6,855.56%608K44.09%-71K67.48%-254K8.33%-11K450.00%203K-101.24%-9K-188.64%-127K-779.13%-781K
Operating profit 56.63%-2.64M74.17%-1.92M30.53%-4.59M10.14%-24.03M31.57%-3.91M-33.57%-6.09M4.20%-7.42M24.24%-6.6M30.39%-26.74M39.57%-5.72M
Net non-operating interest income expense -12.83%-5.37M-42.87%-5.87M-135.13%-4.48M-18.17%-6.87M-29.48%3.91M13.15%-4.76M-1,021.52%-4.11M36.26%-1.91M-122.00%-5.81M3,303.07%5.55M
Non-operating interest income 154.82%502K54.98%420K-49.53%692K-0.92%1.08M-43.98%-694K-65.07%197K--271K--1.37M770.40%1.09M---482K
Non-operating interest expense 18.47%5.88M43.62%6.29M57.90%5.18M36.67%7.63M32.99%-4.92M-17.99%4.96M2,346.67%4.38M9.56%3.28M111.76%5.58M-4,966.90%-7.35M
Total other finance cost -------------75.95%317K----------------1,131.78%1.32M----
Other net income (expense) 35.61%-6.79M-250.32%-10.55M
Gain on sale of security ------------216.75%941K-----------------794.83%-806K----
Special income (charges) ------------20.62%-7.73M-----------------211.54%-9.74M----
-Less:Restructuring and merger&acquisition -------------52.75%4.6M----------------368.37%9.74M----
-Less:Other special charges --------------3.13M------------------------
Income before tax 26.15%-8.02M32.44%-7.79M-6.59%-9.07M12.56%-37.69M36.63%-6.79M-8.06%-10.86M-8.49%-11.53M27.31%-8.51M2.15%-43.1M12.92%-10.72M
Income tax -101.80%-6K-416K137K38,100.00%382K4,700.00%48K334K001K-99.22%1K
Net income 28.41%-8.01M36.05%-7.37M-8.20%-9.21M11.67%-38.07M36.18%-6.84M-11.39%-11.19M-8.49%-11.53M27.31%-8.51M2.14%-43.1M13.81%-10.72M
Net income continuous Operations 28.41%-8.01M36.05%-7.37M-8.20%-9.21M11.67%-38.07M36.18%-6.84M-11.39%-11.19M-8.49%-11.53M27.31%-8.51M2.14%-43.1M13.81%-10.72M
Minority interest income
Net income attributable to the parent company 28.41%-8.01M36.05%-7.37M-8.20%-9.21M11.67%-38.07M36.18%-6.84M-11.39%-11.19M-8.49%-11.53M27.31%-8.51M2.14%-43.1M13.81%-10.72M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 28.41%-8.01M36.05%-7.37M-8.20%-9.21M11.67%-38.07M36.18%-6.84M-11.39%-11.19M-8.49%-11.53M27.31%-8.51M2.14%-43.1M13.81%-10.72M
Basic earnings per share 60.00%-0.1666.67%-0.1438.71%-0.1930.12%-1.1664.10%-0.14-8.11%-0.4-10.53%-0.4241.51%-0.3140.29%-1.6650.00%-0.39
Diluted earnings per share 60.00%-0.1666.67%-0.1438.71%-0.1930.12%-1.1664.10%-0.14-8.11%-0.4-10.53%-0.4241.51%-0.3140.29%-1.6650.00%-0.39
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More